Glioblastoma, the most aggressive cancer that begins in the brain, has stubbornly resisted decades of progress in oncology.
For two decades, neurosurgeons have relied on glowing dyes to help them see the invisible margins of glioblastoma, the most ...
Glioblastoma—the most aggressive form of brain cancer—remains one of medicine's biggest challenges. Despite surgery, radiotherapy, and chemotherapy, most patients survive only about a year after ...
A new AI-based model can predict where glioblastoma is most likely to return after initial surgery, potentially giving ...
Glioma therapy often fails due to the acquisition of temozolomide (TMZ) resistance. Antiepileptic drugs, valproic acid (VPA) and levetiracetam (LEV) are commonly used during the perioperative period ...
Glioblastoma is the most common primary intracranial malignant tumor in adults and has high morbidity and high mortality. TMEM158 has been reported to promote the progression of s ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Glioblastoma multiforme is an aggressive brain tumor that mainly affects adults. Approximately 30,000 people in the U.S. are diagnosed with GBM every year and patients have a 5-year survival rate of 7 ...
Medical researchers have announced the results of an innovative treatment approach that may offer improvement in overall survival in older patients with newly diagnosed glioblastoma while maintaining ...
For years, cancer researchers have noticed that more men than women get a lethal form of brain cancer called glioblastoma. They've also found that these tumors are often more aggressive in men. But ...
BOSTON, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NeuroNOS, a biopharmaceutical company focused on developing treatments for neurological disorders and neuro-oncology, and a subsidiary of Beyond Air (NASDAQ: ...
When you have glioblastoma, a pathology report documents vital information about your brain tumor, which helps your healthcare team decide on the best treatment path. But trying to make sense of the ...